id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-E-6700-0002,FDA,FDA-2017-E-6700,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2017-12-01T05:00:00Z,2017,12,2017-12-01T05:00:00Z,,2017-12-01T14:36:28Z,,0,0,0900006482cca18d
FDA-2017-E-6700-0001,FDA,FDA-2017-E-6700,Patent Extension Application from Novartis Pharmaceuticals Corp,Other,Application,2017-12-01T05:00:00Z,2017,12,2017-12-01T05:00:00Z,,2017-12-01T14:30:25Z,,0,0,0900006482cca189